AGK-102
N/A
Report date: 2023/09/28 14:39:42
First In Class
Base Information
Drug NameAGK-102
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorea Atomic Energy Research Institute
China Registration ClassN/A
Develop Information
Active CompaniesAlgok Bio IncKorea Atomic Energy Research Institute
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A